Uptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer
Despite their efficacy, uptake of selective estrogen receptor modulators for breast cancer chemoprevention remains low. Exemestane, an aromatase inhibitor, has recently been identified as a potential chemopreventive option with fewer serious side effects compared with selective estrogen receptor mod...
Main Authors: | , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Lippincott Williams & Wilkins
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885537/ |